Employees: 441
Size Shandong Sanyuan Biotechnology (301206.SZ) is a China Materials company (Chemicals: Major Diversified) with a market value of $644M, the 3083rd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥21.38 on 18 Nov 2026.
Performance Over six months the shares fell 20.7%, against -27.3% for the median peer and -20.0% for the China market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue grew 15.4% over the last twelve months (peer median +6.3%); the operating margin is 4.2% (peer median 6.4%).
Valuation It trades at 3.7× enterprise value to sales against a peer median of 3.3× (10th most expensive of 21).
Capital Return on invested capital runs 5.4 points below its cost of capital (7.9% WACC).
Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥778M | CN¥649M | CN¥713M | CN¥500M | CN¥675M |
| Revenue growth | — | -9% | +43% | -26% | — |
| Gross profit | CN¥166M | CN¥94.8M | CN¥73.3M | CN¥6.14M | CN¥85.9M |
| EBITDA | n/a | CN¥102M | CN¥73.7M | CN¥176,270 | CN¥69.3M |
| Net income | CN¥77.7M | CN¥91.4M | CN¥105M | CN¥56.0M | CN¥164M |
| Free cash flow | -CN¥3.24M | CN¥119M | -CN¥121M | -CN¥65.7M | -CN¥158M |
| Capital expenditure | CN¥163M | CN¥199M | CN¥142M | CN¥123M | CN¥243M |
| Total debt | CN¥14.6M | CN¥10.8M | CN¥94.8M | CN¥165M | CN¥102M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301206.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -12.9% | -9.9% | 8th lowest of 21 |
| 6-month return | -20.7% | -27.3% | 9th highest of 21 |
| Distance from 52-week high | -29.9% | -40.7% | 6th highest of 21 |
| Revenue growth (TTM) | +15.4% | +6.3% | 3rd highest of 21 |
| Operating margin | 4.2% | 6.4% | 8th lowest of 21 |
| EV / Sales | 3.7× | 3.3× | 10th most expensive of 21 |
| ROIC minus cost of capital | -5.4 pp | -1.8 pp | 8th lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shandong Sanyuan Biotechnology 301206.SZ | China | $644M | -21% | +15% | 4% | 3.7× | n/a | n/a |
| Ningxia Yinglite Chemicals 000635.SZ | China | $650M | +35% | -14% | -48% | 3.2× | n/a | n/a |
| Jiansu Huachang Chemical 002274.SZ | China | $663M | -25% | +9% | -3% | 0.7× | 23.2% | +1.3% |
| Liaoning Oxiranchem,Inc 300082.SZ | China | $673M | -45% | +4% | 0% | 1.3× | n/a | n/a |
| Ningxia Zhongke Biotechnology 600165.SS | China | $601M | -17% | +8% | -73% | 7.7× | n/a | n/a |
| Hunan Lead Power Technology 300530.SZ | China | $691M | +12% | +16% | -61% | 31.9× | n/a | n/a |
| Hubei Chaozhuo Aviation Technology 688237.SS | China | $697M | -5% | -1% | 1% | 10.8× | 43.1% | +26.0% |
| Shandong Jianbang New Material 603285.SS | China | $594M | -50% | +8% | 22% | 4.8× | n/a | n/a |
| Shandong Yanggu Huatai Chemical 300121.SZ | China | $703M | -16% | +11% | 8% | 1.2× | 4.7% | +12.1% |
| Daxin Materials 5234.TW | Taiwan | $705M | -39% | +12% | 20% | 4.5× | 15.9% | +1.5% |
| Hunan Xiangtou Goldsky Titanium Industry Technology 688750.SS | China | $585M | -29% | +4% | 6% | 6.2× | 28.9% | -4.3% |
| Zhejiang Dragon Technology 603004.SS | China | $582M | -22% | -11% | 16% | 4.2× | 15.8% | +1.7% |
| Shandong Taihe Technologies 300801.SZ | China | $582M | -42% | -2% | 7% | 1.2× | 5.2% | +12.9% |
| Archean Chemical Industries ACI.NS | India | $576M | -19% | +6% | 12% | 5.0× | n/a | n/a |
| Jiangsu Kuangshun Photosensitivity New Material Stock 300537.SZ | China | $568M | -33% | +15% | 6% | 6.5× | 41.7% | -8.5% |
| Jiangxi Hungpai New Material 605366.SS | China | $736M | -46% | +9% | -11% | 3.2× | n/a | n/a |
| KH Neochem 4189.T | Japan | $738M | +20% | -6% | 12% | 1.2× | -5.0% | +8.3% |
| JCU 4975.T | Japan | $744M | -34% | +5% | 39% | 3.0× | 5.5% | +7.0% |
| Nanjing Well Pharmaceutical 603351.SS | China | $550M | -2% | +7% | 13% | 2.7× | 3.0% | +12.7% |
| Ningbo Bohui Chemical Technology 300839.SZ | China | $533M | -35% | +42% | 4% | 1.0× | 1.2% | +23.1% |
| China Catalyst 688267.SS | China | $532M | -38% | -3% | 18% | 3.4× | n/a | n/a |